1,2-Dichloroethane → HCID 178521727, compound

HRID 1047561Notes

Reaction equation

HRID 1047561 reaction equation
[F:1][C:2]1([F:8])[CH2:4][CH:3]1[C:5](O)=[O:6].N1(O)C2C=CC=CC=2N=N1.C(Cl)CCl.C(=O)(O)[O-].[Na+].[O:28]1[CH2:33][CH2:32][N:31]([C:34]2[CH:58]=[CH:57][C:37]3[NH:38][C:39]([C:41]4[C:49]5[C:44](=[CH:45][CH:46]=[C:47]([NH2:50])[CH:48]=5)[N:43]([CH:51]5[CH2:56][CH2:55][CH2:54][CH2:53][O:52]5)[N:42]=4)=[N:40][C:36]=3[CH:35]=2)[CH2:30][CH2:29]1>CN(C=O)C>[F:1][C:2]1([F:8])[CH2:4][CH:3]1[C:5]([NH:50][C:47]1[CH:48]=[C:49]2[C:44](=[CH:45][CH:46]=1)[N:43]([CH:51]1[CH2:56][CH2:55][CH2:54][CH2:53][O:52]1)[N:42]=[C:41]2[C:39]1[NH:38][C:37]2[CH:57]=[CH:58][C:34]([N:31]3[CH2:32][CH2:33][O:28][CH2:29][CH2:30]3)=[CH:35][C:36]=2[N:40]=1)=[O:6]

Participants

7

Procedure

2,2-Difluorocyclopropanecarboxylic acid (6.42 mg, 0.053 mmol), 1H-benzo[d][1,2,3]triazol-1-ol (9.69 mg, 0.072 mmol), EDC (13.74 mg, 0.072 mmol) and sodium bicarbonate (4.01 mg, 0.048 mmol) was added to a solution of 3-(5-morpholino-1H-benzo[d]imidazol-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-amine (20 mg, 0.048 mmol) in DMF (6 mL). The reaction mixture was stirred at room temperature for 24 h, and then the solvent was removed in vacuo. Upon purification by flash chromatography (6% CH3OH/CH2Cl2) afforded the title compound (15 mg). 1H NMR: (400 MHz, CD3OD): δ 8.51 (s, 1H), 7.76-7.72 (m, 1H), 7.68 (m, 1H), 7.58 (m, 1H), 7.05 (m, 2H), 5.86 (dd, 1H, J=2.4 and 9.6 Hz), 3.99 (m, 1H), 3.86 (m, 4H), 3.81 (m, 1H), 3.16 (m, 4H), 2.77-2.69 (m, 1H), 2.61 (m, 1H), 2.18-2.08 (m, 3H), 1.89-1.80 (m, 2H), 1.74-1.68 (m, 2H); ESI-MS [M+H]+: 523.2.

Workup

  1. customthe solvent was removed in vacuo
  2. customUpon purification by flash chromatography (6% CH3OH/CH2Cl2)

Sources & evidence

ORD record
ord-b84fdbebd66e45c594accb76d84e42e5
Source dataset
uspto-grants-2013_10
Patent number
US08569511B2

Reaction notes

Loading…